According to Fact.MR’s most recent industry analysis, implanted medical device market sales are expected to grow globally between 2022 and 2027 at a compound annual growth rate of 6.1%. The market for implantable medical devices is expanding as a result of increased chronic illness prevalence, an ageing population, and improvements in active implanted medical devices. Additionally, increased funding and investments in the creation of technologically advanced products, elevated awareness of advancements in medical implants, and an increase in the use of neurostimulators are all contributing to market expansion. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7728 Incidence of cardiovascular diseases is rising, and obesity rates are high, which are the main drivers that are likely to fuel market growth for implantable medical devices. Medical professionals and patients can monitor their illnesses to receive an early update with the use of implantable medical devices. These wireless, automated devices assess a patient’s sensitivity to a prescribed medicine dosage. The rising prevalence of neurological illnesses such as Parkinson’s disease and spasticity is driving the demand for active implantable medical devices. Key Takeaways from Market Study The global implantable medical devices market is predicted to reach US$ 155 billion by 2027. Market in Canada is projected to evolve at a CAGR of 5.5% over the forecast period (2022-2027). Market in Germany is forecasted to rise at a CAGR of 4% through 2027. Demand for cardiovascular implants is predicted to increase at a CAGR of 5.8% from 2022 to 2027. “Increasing investments in R&D by government organizations for product innovations, rising adoption of innovative implantation methods such as robot-assisted orthopedic surgeries, growing awareness of the accessibility of implantable medical devices, rising disposable income, and growing consumer spending on healthcare services are factors driving market growth,” says a Fact.MR analyst Key Companies Profiled Silimed Straumann Stryker Corporation Allergan PLC CEREPLAS BioHorizons IPH, Inc. Implantech Dentsply Sirona, Inc. Establishment Labs S.A. GROUPE SEBBIN SAS Heraeus Holding GmbH Ideal Implant Inc. Ivoclar Vivadent AG Nobel Biocare Holding AG Osstem Implant Co., Ltd. Polytech Health & Aesthetics GmbH Implantable medical devices market size, growth forecast by Fact.MR Winning Strategy Top market participants are concentrating on creating customized implants. Additional factors driving market growth include established distribution channels and strategic alliances with significant service providers to broaden product reach. Key market players are offering technologically advanced implantable medical devices to gain an advantage in the extremely competitive industry. For instance, In 2021, a total knee system without cement was introduced by Smith & Nephew. Conceloc Advanced Porous Titanium, a proprietary material that is patented for 3D printing, is used to make the implant. Medtronic obtained innovative device designation from the FDA for completely implantable left ventricular assist equipment for patients with severe heart failure. This recognition will enable the organization to treat or diagnose diseases that are life-threatening more effectively, increasing the size of its clientele. Industry Research By Product Type : Orthopedic Implants Cardiovascular Implants Dental Implants Intraocular Lens Breast Implants Others By Material : Ceramic Metal Polymer By Nature of Device : Active Passive By End User : Hospitals Ambulatory Surgical Centers Multi-specialty Centers By Region : North America Europe Asia Pacific Latin America Middle East & Africa Why is the market for implantable medical devices growing in the United States? The drivers driving market expansion in the U.S. include rising consumer healthcare spending, increased use of minimally invasive procedures, and increased public knowledge of the availability of different medical implants. Constant improvements in medical technology, the availability of state-of-the-art healthcare facilities with qualified medical staff, expanding consumer demand for active implanted devices, and rising government spending in the healthcare system all contribute to the market’s value growth. More Valuable Insights on Offer Fact.MR, in its new offering, presents an unbiased analysis of the global implantable medical devices market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027. The study divulges essential insights on the market on the basis of product type (orthopedic implants, cardiovascular implants, dental implants, intraocular lens, breast implants, others), material (ceramic, metal, polymer), nature of device (active, passive), and end user (hospitals, ambulatory surgical centers, multi-specialty centers), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA). Get Customization on this Report for Specific Research Solutions- https://www.factmr.com/connectus/sample?flag=RC&rep_id=7728
Last changed by  
 
Factmrsurvey
40

Read more

Untitled

By the end of 2033, the chronic idiopathic constipation treatment market is expected to have grown from a projected value of US$ 9.4 billion in 2023 to US$ 19.7 billion, expanding quickly at a CAGR of 7.5%. When a person has difficult, infrequent, and/or suboptimal defecation, it is known as chronic idiopathic constipation (CIC), a common functional bowel disorder. Chronic idiopathic constipation is becoming more common due to factors like sedentary lifestyles, growing anti-inflammatory medicine use, and a rapid decline in dietary fibre consumption. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8517 Additionally, rising rate of the ageing population, sedentary lifestyles, and dietary changes are contributing to the increasing burden of CIC, thereby driving the demand for treatment options. Fiber supplements, laxatives, stool softeners, and prokinetic agents are commonly used as medications in the management of CIC. Furthermore, advancements in digital health technologies are also shaping the future of chronic idiopathic constipation treatment. Mobile applications, wearable devices, and remote monitoring tools are being developed to help patients track their bowel movements, diet, and exercise habits, and provide personalized recommendations for managing CIC.

8/7/2023
Untitled

The Automotive Ceramics Industry sales study offers a comprehensive analysis on diverse features including production capacities, Automotive Ceramics demand, product developments, sales revenue generation and Automotive Ceramics market outlook across the globe. 170 page market research report by Fact.MR, (Leading business and competitive intelligence provider) on global Automotive Ceramics market sales initiates with an outlook of the market, followed by the scrutiny of the demand and consumption volumes and share and size of various end-use segments The global automotive ceramics market was valued at US$ 2.3 Billion in 2021 and market is valued at US$ 2.42 Billion in 2022 During the 2022-2032 period of assessment, demand is expected to rise at a 5.4% value CAGR, likely to reach US$ 6.6 Billion by the end of the said forecast period. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=6406 The readability score of the Automotive Ceramics market demand report is good as it offers chapter-wise layout with each section divided into a smaller sections.

8/7/2023
Preimplantation Genetic Testing Market to Hit Valuation of US$ 1,420 Million by 2032

Through 2032, the preimplantation genetic testing market is anticipated to develop at a CAGR of around 9% and reach a significant market size. Growth opportunities are expanding as a result of the rising prevalence of genetic illnesses. The market is anticipated to reach US$ 653.52 million by 2022 and will continue to grow, reaching US$ 1,420 million by 2032. Download Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=292 The biggest benefit offered by preimplantation testing is it offers an opportunity to conceive a pregnancy unaffected by genetic conditions. Researchers and healthcare institutes are trying to find new methods and techniques using the latest technology to minimize various risks associated with preimplantation genetic testing. Key Highlights

8/7/2023
Worldwide Shipments of Anesthesia Monitoring Devices are Anticipated to Increase at an Impressive CAGR of 9.1% by 2032

Anaesthesia monitoring equipment market sales are anticipated to grow globally between 2022 and 2027 at a strong CAGR of 9.1%. The market for anaesthesia monitoring devices is currently worth US$ 2.2 billion. Since there has been a noticeable rise in the prevalence of chronic diseases, more surgeries are being conducted, which increases the demand for anaesthesia apparatus, including anaesthesia monitoring devices. A growing elderly population, rising healthcare costs, and product technology developments are further variables that may boost demand for anaesthesia monitoring devices. The expensive cost of anaesthesia monitoring equipment, however, is anticipated to limit market potential to some degree. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7683 Anesthesia monitoring device manufacturing companies are focusing on the expansion of their product portfolios and are also expanding their business scope by gaining new approvals from regulatory authorities. In April 2022, GE Healthcare, a leading name in the medical industry, announced that it had received pre-market approval from the U.S. FDA for its new software to deliver general anesthesia. The End-Tidal (Et) Control software is cleared to be used on GE’s Aisys CS2 Anesthesia Delivery System.

8/7/2023
Read more from Factmrsurvey
Published on HackMD